| Document And Entity Information | Mar. 01, 2024 |
| Cover [Abstract] | |
| Document Type | 8-K |
| Amendment Flag | false |
| Document Period End Date | Mar. 01, 2024 |
| Entity Registrant Name | Biodesix, Inc. |
| Entity Central Index Key | 0001439725 |
| Entity File Number | 001-39659 |
| Entity Incorporation State Country Code | DE |
| Entity Tax Identification Number | 20-3986492 |
| Entity Address, Address Line One | 919 West Dillon Rd |
| Entity Address, City or Town | Louisville |
| Entity Address, State or Province | CO |
| Entity Address, Postal Zip Code | 80027 |
| City Area Code | 303 |
| Local Phone Number | 417-0500 |
| Written Communications | false |
| Soliciting Material | false |
| Pre-commencement Tender Offer | false |
| Pre-commencement Issuer Tender Offer | false |
| Entity Emerging Growth Company | true |
| Entity Ex Transition Period | false |
| Security 12b Title | Common Stock, par value of $0.001 per share |
| Trading Symbol | BDSX |
| Security Exchange Name | NASDAQ |
